Arrowhead (ARWR) Sees Stock Surge Following Strategic Collaboration
As of the last check, Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stock was trading up 17.32% to $22.04, a remarkable increase on the charts. Announcement of its strategic license and partnership deal with Sarepta Therapeutics is propelling the surge. This agreement represents a major turning point in ARWR’s journey from development to commercialization and offers the […]
Arrowhead (ARWR) Sees Stock Surge Following Strategic Collaboration Read More »